Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of hLF1-11 in HSCT recipients
NCT00430469Phase 2Withdrawn
- Sponsor
- AM-Pharma
- Start
- Nov 2008
- Primary completion
- Mar 2009
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of human lactoferrin peptide 1-11 in bacterial infection, fungal infection, sponsored by AM-Pharma. Planned start Nov 2008; status: withdrawn.
02
Drugs
human lactoferrin peptide 1-11
03
Conditions
bacterial infectionfungal infection
Beyond the preview
Go deeper on NCT00430469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00430469.